• $24.8M
    Market Cap
  • 88.89%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
3.0M
+71.61%
1.8M
+35.25%
1.3M
-98.14%
70.0M
-19.54%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
1.4M
-92.58%
Gross Profit
3.0M
+71.61%
1.8M
+35.25%
1.3M
-98.10%
68.6M
+0.67%
Sales and Marketing Expense
N/A
N/A
4.7M
-64.06%
13.2M
0.00%
13.2M
-87.80%
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
384,000
-24.56%
509,000
-44.79%
922,000
-22.72%
1.2M
-70.85%
Total Operating Expenses
7.4M
+13.66%
6.5M
-33.63%
9.8M
-85.42%
67.4M
-67.59%
Operating Profit
-4.4M
-7.77%
-4.8M
-44.15%
-8.5M
-815.62%
1.2M
+100.85%
Interest Income
142,000
-2.00%
144,900
N/A
N/A
N/A
N/A
N/A
Interest Expense
-8,000
-15.79%
-9,500
-96.83%
-300,000
-99.17%
-36.1M
+9.56%
Interest Income and Expense and Net
134,000
-1.03%
135,400
+145.13%
-300,000
-99.17%
-36.1M
+10.48%
Total Nonoperating Income and Expense
3.7M
+54.61%
2.4M
+209.48%
781,000
+767.52%
-117,000
-99.64%
Income before Taxes
-653,000
-72.13%
-2.3M
-69.74%
-7.7M
-820.86%
1.1M
+100.62%
Income Taxes
N/A
N/A
-31,000
-27.91%
-43,000
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-569,000
-73.91%
-2.2M
-78.78%
-10.3M
-109.18%
112.0M
+164.96%
Net Income from Continuing Operations Applicable to Common
-653,000
-71.76%
-2.3M
-69.97%
-7.7M
-816.85%
1.1M
+100.62%
Basic EPS and Net Income
-0.05
-73.68%
-0.19
-80.61%
-0.98
-107.90%
12.41
+2,986.05%
Diluted EPS and Net Income
-0.05
-73.68%
-0.19
-80.61%
-0.98
-108.19%
11.96
+2,881.40%
Basic Weighted Average Shares
11.6M
+100,220.85%
11,532
-99.89%
10.4M
+15.65%
9.0M
-97.73%
Diluted Weighted Average Shares
11.6M
+100,220.85%
11,532
-99.89%
10.4M
+11.48%
9.4M
-97.65%
Balance Sheet
Cash and Cash Equivalents
7.5M
+47.91%
5.1M
+16.92%
4.3M
-88.63%
38.1M
-41.55%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.5M
+47.91%
5.1M
+16.92%
4.3M
-88.63%
38.1M
-41.55%
Total Current Assets
14.4M
+17.83%
12.3M
+3.93%
11.8M
-78.69%
55.4M
-53.67%
Accumulated Depreciation
N/A
N/A
N/A
N/A
2.5M
+3.15%
2.4M
-2.90%
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
78,000
-93.49%
Total Long-Term Assets
444,000
+241.54%
130,000
+124.14%
58,000
-77.08%
253,000
0.00%
Total Assets
37.7M
-3.00%
38.8M
-10.36%
43.3M
-52.12%
90.5M
-46.62%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
188.3M
0.00%
Total Current Liabilities
4.8M
-7.38%
5.2M
-24.63%
6.9M
-85.37%
46.8M
-81.48%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
188.3M
N/A
Total Long-Term Liabilities
873,000
+17.34%
744,000
+16.98%
636,000
-42.55%
1.1M
-48.25%
Total Liabilities
10.8M
-5.87%
11.5M
-18.33%
14.0M
-74.65%
55.3M
-78.98%
Retained Earnings
-952.4M
+0.06%
-951.8M
+0.23%
-949.6M
+1.09%
-939.4M
-10.65%
Total Stockholders Equity
26.9M
-1.80%
27.4M
-6.55%
29.3M
-16.66%
35.1M
+137.54%
Total Shares Outstanding
11.6M
+0.36%
11.5M
0.00%
11.5M
+21.42%
9.5M
-97.79%
Cash Flow
Cash from Operating Activities
2.4M
+231.15%
732,000
+101.52%
-48.1M
+1,080.51%
-4.1M
-97.14%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
34,000
0.00%
Cash from Investing Activities
N/A
N/A
N/A
N/A
0
-100.00%
223.5M
+10,153.04%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
N/A
N/A
3.2M
+101.34%
-235.2M
-281.55%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
98.00%
+25.11%
Operating Margin
-145.27%
-46.26%
-270.30%
-58.71%
-654.61%
-38,554.34%
1.70%
+101.06%
Return on Assets
-1.49%
-71.98%
-5.31%
-65.44%
-15.37%
-117.83%
86.17%
+187.74%
Return on Equity
-2.10%
-72.75%
-7.70%
-75.87%
-31.90%
-91.67%
-383.04%
-341.74%
Revenue Growth
71.61%
+103.12%
35.25%
+135.92%
-98.14%
+402.31%
-19.54%
-157.41%
Current Ratio
3.02
+27.21%
2.37
+37.88%
1.72
+45.64%
1.18
+150.15%
Cash Ratio
1.56
+59.69%
0.98
+55.12%
0.63
-22.32%
0.81
+215.61%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
10.71
+632.79%
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
4.16
+274.71%

Earnings & Revenue History

Debt-to-Assets

Cash Flow